This is a preview of subscription content, log in via an institution to check access.
References
AJ Clayton S Danson S. Jolly et al. (2004) ArticleTitleIncidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer Br J Cancer 91 IssueID4 639–643 Occurrence Handle15266327
E Shmueli N Wigler M. Inbar (2004) ArticleTitleCentral nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment Eur J Cancer 40 IssueID3 379–382 Occurrence Handle10.1016/j.ejca.2003.09.018 Occurrence Handle14746856
JC Bendell SM Domchek HJ. Burstein et al. (2003) ArticleTitleCentral nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma Cancer 97 2972–2977 Occurrence Handle10.1002/cncr.11436 Occurrence Handle12784331
H Hurwitz L Fehrenbacher T. Cartwright et al. (2003) ArticleTitleBevacizumab (a monoclonal antibody to vascular endothelial growth factor) prolongs survival in first-line colorectal cancer (CRC): results of a phase III trial of bevacizumab in combination with bolus IFL (irinotecan, fluorouracil, leucovorin as first-line therapy in subjects with metastatic CRC [Abstract] Proc Am Soc Clin Onco 22 A-3646
D Cunningham Y Humblet S. Siena et al. (2003) ArticleTitleCetuximab (C225) alone or in combination with irinotecan (CPT-11 in patients with epidermal growth factor receptor (EGFR-positive, irinotecan-refractory metastatic colorectal cancer (MCRC) [Abstract] Proc Am Soc Clin Onco 22 A-1012–252
H Hurwitz L Fehrenbacher W. Novotny et al. (2004) ArticleTitleBevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 IssueID23 2335–2342 Occurrence Handle10.1056/NEJMoa032691 Occurrence Handle15175435
MG Kris RB Natale RS. Herbst et al. (2003) ArticleTitleEfficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial JAMA 290 IssueID(16 2149–2158 Occurrence Handle10.1001/jama.290.16.2149 Occurrence Handle14570950
M Fukuoka S Yano G. Giaccone et al. (2003) ArticleTitleMulti-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer J Clin Oncol 21 IssueID12 2237–2246 Occurrence Handle10.1200/JCO.2003.10.038 Occurrence Handle12748244
JD Hainsworth JA Sosman DR Spigel et al. (2004) ArticleTitlePhase II trial of bevacizumab and erlotinib in patients with metastatic renal carcinoma (RCC) Proc Am Soc Clin Oncol 22 4502
RJ Motzer Rini BI MD. Michaelson et al. (2004) ArticleTitleSU011248, a novel tyrosine kinase inhibitor, shows antitumor activity in second-line therapy for patients with metastatic renal cell carcinoma: results of a phase 2 trial Proc Am Soc Clin Oncol 22 4500
F Bokstein A Lossos T. Siegal (1997) ArticleTitleLeptomeningeal metastases in solid tumors: exclusion of intra-CSF chemotherapy does not affect treatment outcome. Comparison of two prospective series Neurology 48 IssueID2 A35
T. Siegal (1998) ArticleTitleLeptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy? J Neurooncol 38 151–157 Occurrence Handle10.1023/A:1005999228846 Occurrence Handle9696366
R Patchell PA Tibbs WF. Regine et al. (2003) ArticleTitleA randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis Proc Am Soc Clin Oncol 22 1
R Lai CT Dang MG. Malkin et al. (2004) ArticleTitleThe risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma Cancer 101 810–816 Occurrence Handle10.1002/cncr.20418 Occurrence Handle15305414
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Taillibert, S., Delattre, JY. Metastatic Tumors of the Nervous System. J Neurooncol 75, 1–3 (2005). https://doi.org/10.1007/s11060-004-8092-7
Issue Date:
DOI: https://doi.org/10.1007/s11060-004-8092-7